Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
about
Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of researchRedox regulation, NF-kappaB, and atrial fibrillation.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.Left ventricular hypertrophy in hypertension: its arrhythmogenic potential.Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade.Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.Heart failure: epidemiology and prevention in India.Value of Angiotensin receptor blocker therapy in diabetes.Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization.Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death.Single-center evaluation of the single-dose pharmacokinetics of the angiotensin II receptor antagonist azilsartan medoxomil in renal impairment.Different protein kinase C isoenzymes mediate inhibition of cardiac rapidly activating delayed rectifier K+ current by different G-protein coupled receptors.Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad LatinoamCandesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.Klinischer Einsatz von Beta-Blockern bei kardiovaskulären Indikationen: Neue Therapiestudien
P2860
Q28272171-000D0CBC-EE74-4C01-AE0C-273FC20D3EFCQ33644314-DA72CED5-51A6-4118-865A-C7358C5FC1CEQ34299778-F4FC94E5-7DC1-41F0-AA73-E363DFE0281BQ35176717-FEECC591-9C56-4716-A8A7-524147BDDD8EQ35583519-854C9BC2-E4AA-40E0-8FD2-B49AF9403824Q36060436-5DC0332F-2195-4708-9438-5CDC172E2D98Q36242608-9939CED4-71DC-4515-9E42-0AEFC6E34327Q36249947-F6371EA6-F203-4AB3-A4C6-3DC80B375037Q36741895-B6E22700-06A9-4E53-9BC2-D7DF73FF40B8Q37554391-FFBADCC5-47FA-41BC-BB2A-35777EB0785CQ37861891-CECA6EF2-63C3-47A0-A327-8998D97C799EQ40519791-76B259BF-06EB-4F1F-99D9-2910225764DEQ41466432-11F65180-F796-4376-B844-1B0B72F02C85Q44383088-6EF9B77B-CF96-46A2-B8CC-86EEED5B3A18Q46606748-168FB47D-4A1A-46EE-99D0-0B27545DA1F9Q47775639-9109A0AA-5359-458A-A443-2697808BD38BQ51800530-4AF736BF-7375-4B9F-B1D1-B9F00B62790CQ56624513-2020A6F1-5D13-434D-8642-B9BB21995C2D
P2860
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@ast
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@en
type
label
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@ast
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@en
prefLabel
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@ast
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@en
P2093
P1433
P1476
Effect of losartan on sudden c ...... tes: data from the LIFE study.
@en
P2093
Hans Ibsen
Jonathan M Edelman
Knut Borch-Johnsen
Kristian Wachtell
LIFE study group
Lars H Lindholm
Michael Hecht Olsen
Steven Snapinn
P304
P356
10.1016/S0140-6736(03)14183-9
P407
P50
P577
2003-08-01T00:00:00Z